NAMPT is the rate-limiting enzyme in the NAD salvage pathway, and E2F2 acts downstream of NAMPT and controls ID1 gene transcription to drive glioblastoma CSC self-renewal. This evidence concerns the gene NAMPT and glioblastoma.